Market Tracker

10/21 6:05pm ET

Novo Nordisk A/S (NYSE:NVO)

During the Trading Day
45.43 +0.48 / +1.07%
Data as of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
45.46 +0.03 / +0.07%
 
Volume: 58.5K

Today’s Trading

Previous close44.95
Today’s open44.82
Day’s range44.67 - 45.46
Volume1,653,706
Average volume (3 months)1,082,116
Market cap$93.4B
Dividend yield1.83%
Data as of 4:02pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+23.61%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+10.11%
P/E ratio--
Price/Sales6.64
Price/Book15.13

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie Inc+1.88+3.46%
AZNAstraZeneca PLC+1.05+1.55%
BMYBristol-Myers Squibb...+1.39+2.75%
GSKGlaxoSmithKline PLC+0.02+0.05%
Data as of 4:04pm ET, 10/21/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)$0.44
Annual revenue (last year)$14.9B
Annual profit (last year)$4.5B
Net profit margin30.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Bagsvrd, --

Forecasts